FDA approved the Genio system for the U.S. market on August 19, 2025, following company reports from Mont-Saint-Guibert and the start of commercial launch.
4 reports, 2 independent
Updated Jul 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 3
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approved the Genio system for the U.S. market on August 19, 2025, following company reports from Mont-Saint-Guibert and the start of commercial launch.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Hospital in North Alabama introduces the FDA-approved Genio system as a new therapy.Sub-event
- FDA approved the Genio system for OSA treatment on August 9, 2025.Sub-event
FDA approved Genio system for U.S. market; company reported from Mont-Saint-Guibert.1 source
Keep exploring
The entities involved
Related events
- Generic medicine services are seeking approval for launch from the FDA.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Providence Medical Technology, Inc. received 510(k) clearance from the FDA and plans to showcase its system at the Henry B. González Convention Center.
- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
Coverage
Newest first; wire copies grouped- GlobeNewswireNyxoah Reports Second Quarter Financial and Operating Results REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company B
- ZacksNyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apne
- GlobeNewswireNyxoah Announces Preliminary Results for the Second Quarter of 2025 Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:0